Schistosoma mansoni: the effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo
- PMID: 6340360
- DOI: 10.1007/BF00934012
Schistosoma mansoni: the effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo
Abstract
The in vivo effects of a subcutaneously-administered subcurative dose (200 mg/kg body weight of mouse) of praziquantel on the structure of Schistosoma mansoni was investigated. Worms were collected at varying times post-treatment and processed for both SEM and TEM examination. Praziquantel caused extensive structural changes to both male and female worms within 15 min of treatment although variations in the amount of drug-induced damaged was observed between male and female worms. In female worms although some tegumental vacuolation was observed within 15 min, the major structural change was an often extensive vacuolisation of the subtegumental tissues followed by varying degrees of structural disruption to the subtegumental and gastrodermal musculature. In male worms the initial effects were a vacuolisation of parts of the dorsal tegument and loss of tegumental cytoplasm due to the pinching off of evaginations of the outer surface. With increasing time post-treatment there was an increase in the amount of tegumental damage, particularly in male worms, with total disruption of parts of the outer surface occurring. Also in male worms there was an increase in the amounts of vacuolisation of the parenchymal tissues and in the degree of structural damage to the musculature. In those female worms where subtegumental damage was not extensive changes in the structure of the differentiating vitelline cells were noted.
Similar articles
-
Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel.Parasitology. 1990 Feb;100 Pt 1:65-72. doi: 10.1017/s0031182000060121. Parasitology. 1990. PMID: 2107508
-
Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel.Parasitology. 1987 Apr;94 ( Pt 2):243-54. doi: 10.1017/s0031182000053920. Parasitology. 1987. PMID: 3108831
-
Schistosoma mansoni: dose-related tegumental surface changes after in vivo treatment with praziquantel.Z Parasitenkd. 1983;69(5):643-53. doi: 10.1007/BF00926674. Z Parasitenkd. 1983. PMID: 6636985
-
In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study.Arzneimittelforschung. 1981;31(3a):544-54. Arzneimittelforschung. 1981. PMID: 7195245
-
A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.Arzneimittelforschung. 1981;31(3a):538-41. Arzneimittelforschung. 1981. PMID: 7016122 Review.
Cited by
-
Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective.Clin Med Res. 2004 Nov;2(4):216-27. doi: 10.3121/cmr.2.4.216. Clin Med Res. 2004. PMID: 15931361 Free PMC article. Review.
-
Derivatives of biarylalkyl carboxylic acid induce pleiotropic phenotypes in adult Schistosoma mansoni in vitro.Parasitol Res. 2016 Oct;115(10):3831-42. doi: 10.1007/s00436-016-5146-7. Epub 2016 May 26. Parasitol Res. 2016. PMID: 27230017
-
Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite.Parasitol Res. 1992;78(8):648-54. doi: 10.1007/BF00931515. Parasitol Res. 1992. PMID: 1480600
-
Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine.Parasitol Res. 2009 Jun;104(6):1407-16. doi: 10.1007/s00436-009-1341-0. Epub 2009 Feb 17. Parasitol Res. 2009. PMID: 19221797
-
Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01142-17. doi: 10.1128/AAC.01142-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28971860 Free PMC article.